Medicare Price Offers, Due Feb. 1, Will Be Informed By Therapeutic Alternatives; That’s A Tall Order

 
• By Cathy Kelly

Analysis of therapeutic alternatives to Amgen’s Enbrel highlights the complexities involved in identifying appropriate comparators.

It's A Lot More Complicated Than It May Have Seemed • Source: Shutterstock

More from Medicare

More from Government Payers